Taysha Gene Therapies, Inc. TSHA Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s total debt?
- Taysha Gene Therapies, Inc. (TSHA) reported total debt of $68.55M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s total debt changed year-over-year?
- Taysha Gene Therapies, Inc.'s total debt increased by 11.2% year-over-year, from $61.63M to $68.55M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s total debt?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s total debt has grown at a 17.2% compound annual growth rate (CAGR), from $37.19M to $70.14M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.